TARAMINO, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.011
EU - Europa 616
AS - Asia 275
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 1.949
Nazione #
US - Stati Uniti d'America 1.001
SE - Svezia 166
CN - Cina 143
IE - Irlanda 95
KR - Corea 67
FI - Finlandia 57
FR - Francia 55
IT - Italia 49
UA - Ucraina 46
DE - Germania 44
SN - Senegal 41
AT - Austria 34
GB - Regno Unito 29
SG - Singapore 24
PL - Polonia 20
VN - Vietnam 18
BE - Belgio 13
CA - Canada 10
JP - Giappone 10
IN - India 9
RU - Federazione Russa 5
EU - Europa 4
BR - Brasile 2
NL - Olanda 2
BD - Bangladesh 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.949
Città #
Chandler 204
Beijing 104
Dublin 94
Ann Arbor 86
Houston 62
Jacksonville 46
Villeurbanne 43
Nyköping 41
Medford 37
Ashburn 36
Vienna 34
Princeton 30
Dearborn 27
Fairfield 24
Torino 22
Wilmington 21
Warsaw 20
Boardman 19
Fremont 15
Singapore 15
Brussels 13
Woodbridge 13
Dong Ket 12
New York 12
Hangzhou 9
Pisa 8
Boston 7
Milan 7
Cambridge 6
Musashino 6
Norwalk 6
Seattle 6
Düsseldorf 5
Guangzhou 5
Verona 5
Des Moines 4
Falls Church 4
Indianapolis 4
Ottawa 4
Redwood City 4
Toronto 4
Washington 4
Fuzhou 3
Los Angeles 3
Mountain View 3
Pune 3
Chengdu 2
Kunming 2
Nanchang 2
Saint Petersburg 2
Shanghai 2
Venezia 2
Aachen 1
Baotou 1
Changsha 1
Dhaka 1
Gatineau 1
Groningen 1
Hamburg 1
Hamm 1
Hefei 1
Istanbul 1
Lachine 1
Lourel 1
Mentana 1
Monmouth Junction 1
Munich 1
Nanjing 1
Philadelphia 1
Piraquara 1
Redmond 1
San Diego 1
San Jose 1
Shaoxing 1
Taipei 1
Tappahannock 1
Wenzhou 1
Xian 1
Yinchuan 1
Zhoushan 1
Totale 1.180
Nome #
Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast 135
Umbelliferone Aminoalkyl Derivatives asInhibitors of Human Oxidosqualene: Lanosterol Cyclase 91
Umbelliferone aminoalkyl derivatives as inhibitors of oxidosqualene cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi and pneumocystis carinii 90
protein -protein interaction in sterol biosynthesis: the relationship between sterol-3-keto reductase and oxidosqualene cyclase 88
4-Methylzymosterone and Other Intermediates of Sterol Biosynthesis from Yeast Mutants Engineered in the ERG27 Gene Encoding 3-Ketosteroid Reductase 84
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis 73
Oxidosqualene cyclase from Trypanosoma cruzi and Pneumocystis carinii expressed in Yeast: a model for the development of novel antiparasitic agents 73
Different interaction between oxidosqualene cyclase and steroid-3-ketoreductase from yeasts to mammals 73
Exploring the access of the substrate to the active site of yeast oxidosqualene cyclase by site-directed mutagenesis. 72
Inhibitory Effect of Umbelliferone Aminoalkyl Derivatives on Oxidosqualene Cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii, Homo sapiens and Arabidopsis thaliana: a structure-activity study 71
Access of the substrate to the active site of yeast oxidosqualene cyclase: an inhibition and site-directed mutagenesis appoach. 70
Design, Synthesis, and Biological Evaluation of New (2E,6E)-10-(Dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol Ethers as Inhibitors of Human and Trypanosoma cruzi Oxidosqualene Cyclase. 69
Characterization of the Channel Constriction Allowingthe Access of the Substrate to the Active Site of YeastOxidosqualene Cyclase 69
Oxidosqualene cyclase from Saccharomyces cerevisiae: a model for the development of novel antifungal and antiparasitic agents 67
Access of the substrate to the active site of yeast oxidosqualene cyclase: a modelling and site-directed mutagenesis approach 67
Characterization of a mutation that results in independence of oxidosqualene cyclase (Erg7) activity from a downstream 3-ketoreductase activity (Erg27) in the yeast ergosterol biosynthetic pathway 67
Access of the substrate to the active site of squalene and oxidosqualene cyclases: comparative inhibition, site-directed mutagenesis and homology-modelling studies. 65
Divergent interactions involving the oxidosqualene cyclase and thesteroid-3-ketoreductase in the sterol biosynthetic pathway ofmammals and yeasts 65
Different Interaction between Oxidosqualene Cyclase and Steroid-3-ketoreductase in Yeast and Mammals 63
Mutation analysis of the yeast 3-ketoreductase (Erg27p) and the effects on ergosterol biosynthesis 62
A mutation in yeast oxidosqualene cyclase (Erg7) makes it independent of 3-ketoreductase activity (Erg27) 62
The Interaction of 3-Keto Reductase and Oxidosqualene Cyclase, Two Key Enzymes in the Ergosterol Biosynthetic Pathway 60
Interaction of Steroid-3-Keto Reductase and Oxidosqualene Cyclase, Two Key Enzymes in the Ergosterol Biosynthetic Pathway 59
Genetic analyses involving interactions between the ergosterol biosynthetic enzymes, lanosterol synthase (Erg7p) and 3-ketoreductase (Erg27p), in the yeast Saccharomyces cerevisiae. 57
Functional characterization by site-directed mutagenesis of human oxidosqualene cyclase (OSC) expressed in Pichia pastoris 56
Interaction of oxidosqualene cyclase with C-4 sterol demethylation complex 55
Protein-protein interactions among ergosterol biosynthesis enzymes Erg7p/Erg27p and two-hybrid interactions involving Are1p and Are2p 54
Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents 54
Access of the substrate to the active site of yeast oxidosqualene cyclase: an inhibition and site-directed mutagenesis approach. 48
Totale 2.019
Categoria #
all - tutte 5.877
article - articoli 0
book - libri 0
conference - conferenze 3.394
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.271


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020248 7 14 18 29 19 54 31 9 18 19 24 6
2020/2021240 35 7 15 18 29 9 11 4 43 10 25 34
2021/2022247 2 9 12 16 9 7 11 14 5 11 85 66
2022/2023479 46 47 6 59 49 132 39 32 37 3 20 9
2023/2024181 24 40 18 12 11 18 0 24 0 3 9 22
Totale 2.019